Dublin, June 25, 2021 (GLOBE NEWSWIRE) -- The "Proteomics Market by Component and Application: Global Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to ResearchAndMarkets.com's offering.
The global proteomics market was valued at $21,122.32 million in 2019 and is projected to reach $49,978.80 million by 2027, registering a CAGR of 12.2% from 2020 to 2027. Proteomics is the study of the structure and functions of proteins. It is a complex study as compared to genomics, as genomes are constant, while proteomes differ depending on the cells and time.
The global proteomics market has witnessed significant growth over the past few years, owing to increased utility of proteomics in the diagnosis of diseases and identification of potential new drugs for the treatment of various diseases. Factors such as rise in focus of key players toward product development, surge in R&D expenditure on proteomics, increase in popularity for personalized medicines, and technological advancements in proteomics are expected to drive the market. However, stringent regulatory approvals, the high cost of instruments, and dearth of qualified researchers are expected to hamper the market growth.
The global proteomics market is segmented on the basis of component, application, and region. On the basis of component, the market is categorized into reagents, instruments, and services. The reagents segment is further classified into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is sub segmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry.
Likewise, the chromatography segment is sub classified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography. The applications covered in the study include drug discovery, disease diagnosis, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key companies profiled in the report include Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher SCIENTIFIC, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation. The other players included in the value chain analysis (but not included in the report) are Becton, Dickinson and Company, Caprion Biosciences, and others.
Key Benefits for Stakeholders
- The study provides an in-depth analysis of the global proteomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
- The report provides a quantitative analysis for the period of 2019-2027 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market by components helps to understand the various types of instruments used across geographies.
- Comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities in these regions.
- Key market players have been profiled in the report and their strategies have been analysed thoroughly to understand the competitive outlook of the global market.
- Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework.
Key Topics Covered:
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Top player positioning
3.3. Porter's five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in popularity of personalized medicines
3.4.1.2. Increase in R&D expenditure
3.4.1.3. Technological advancements associated with proteomics components
3.4.2. Restraints
3.4.2.1. High costs associated with proteomics components
3.4.2.2. Dearth of skilled professionals
3.4.3. Opportunities
3.4.3.1. Lucrative opportunities associated with biomarker identification
3.4.3.2. Developments in mass spectrometry-based proteomics
3.5. COVID-19 impact analysis for proteomics market
CHAPTER 4: PROTEOMICS MARKET, BY COMPONENT
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market size and forecast, by component type
4.2.4. Microarray
4.2.4.1. Market size and forecast
4.2.5. Spectrometry
4.2.5.1. Market size and forecast
4.2.6. X-ray crystallography
4.2.6.1. Market size and forecast
4.2.7. Chromatography
4.2.7.1. Market size and forecast
4.2.8. Electrophoresis
4.2.8.1. Market size and forecast
4.2.9. Immunoassay
4.2.9.1. Market size and forecast
4.2.10. Protein fractionation reagents
4.2.10.1. Market size and forecast
4.2.11. Market analysis, by country
4.3. Instruments
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Microarray
4.3.3.1. Market size and forecast
4.3.4. Spectrometry
4.3.4.1. Market size and forecast
4.3.4.2. Market size and forecast
4.3.4.2.1. Mass spectrometry
4.3.4.2.1.1. Market size and forecast
4.3.4.2.2. NMR spectrometry
4.3.4.2.2.1. Market size and forecast
4.3.5. Chromatography
4.3.5.1. Market size and forecast
4.3.5.2. Market size and forecast
4.3.5.2.1. HPLC systems
4.3.5.2.1.1. Market size and forecast
4.3.5.2.2. Ion chromatography
4.3.5.2.2.1. Market size and forecast
4.3.5.2.3. Affinity chromatography
4.3.5.2.3.1. Market size and forecast
4.3.5.2.4. Supercritical fluid chromatography
4.3.5.2.4.1. Market size and forecast
4.3.6. Electrophoresis
4.3.6.1. Market size and forecast
4.3.7. Surface plasmon resonance
4.3.7.1. Market size and forecast
4.3.8. X-ray crystallography
4.3.8.1. Market size and forecast
4.3.9. Protein fractionation systems
4.3.9.1. Market size and forecast
4.3.10. Market analysis, by country
4.4. Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
CHAPTER 5: PROTEOMICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Drug discovery
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Disease diagnosis
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: PROTEOMICS MARKET, BY REGION
CHAPTER 7: COMPANY PROFILES
7.1. AGILENT TECHNOLOGIES INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. BIO-RAD LABORATORIES, INC.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. BRUKER CORPORATION
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product type portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. DANHER CORPORATION.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. GE HEALTHCARE
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product Portfolio
7.5.5. Business performance
7.6. HORIBA, LTD.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. LI-COR, INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.8. PERKINELMER INC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product Portfolio
7.8.5. Business performance
7.9. THERMO FISHER SCIENTIFic, INC.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. WATERS CORPORATION
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product type portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
For more information about this report visit https://www.researchandmarkets.com/r/99vpb0